Výsledky vyhledávání - "лерканидипин"

Akademický článek

A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 11, Iss 5, Pp 535-542 (2015)

Features and possibility of application of the calcium channel blocker lercanidipine in cardiology practice are discussed. The use of lercanidipine in patients with hypertension is supported by extensive evidences. The use of lercanidipine in certain

Externí odkaz: https://doaj.org/article/df37b2baf8c94223b83e8d69b87ee531

Zobrazit plný text záznamu

Akademický článek

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE

Autor: E. L. Trisvetova

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 10, Iss 3, Pp 339-345 (2015)

Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine – the third-generation calcium channel blocker

Externí odkaz: https://doaj.org/article/64cbd92b46de4273bab9f1cebc90fd81

Zobrazit plný text záznamu

Akademický článek

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS

Autor: E. EL. Trisvetova

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 11, Iss 2, Pp 202-208 (2015)

Despite progress in reducing the risk of hypertension (HT) complications, control of blood pressure (BP) levels remains inadequate. Dihydropyridine calcium channel blockers show antihypertensive effect due to significant vasoselective action with a m

Externí odkaz: https://doaj.org/article/6a68b27051cc4f15b557e22d68acc2b9

Zobrazit plný text záznamu

Akademický článek

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS

Autor: A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 10, Iss 1, Pp 92-98 (2015)

Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented. Advantages and indications for the combination of an ACE inhibitor with a dihydropyridine

Externí odkaz: https://doaj.org/article/4e5cdb29af6341cf9141c6e54d82028a

Zobrazit plný text záznamu

Akademický článek

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION

Autor: O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 9, Iss 1, Pp 79-85 (2015)

Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and

Externí odkaz: https://doaj.org/article/81a64755100446a5a418d2253484a62d

Zobrazit plný text záznamu

Akademický článek

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE

Autor: O. D. Ostroumova, I. I. Kopchenov

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 9, Iss 2, Pp 177-182 (2015)

Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyrid

Externí odkaz: https://doaj.org/article/e47c44056bae4156a7218084ea15cfee

Zobrazit plný text záznamu

Akademický článek

Sovershenstvovanie podkhodov k primeneniyu antagonistov kal'tsiya: fokus na lerkanidipin

Autor: Viktor Viktorovich Fomin, Sergey Valentinovich Moiseev

Publikováno v: КардиоСоматика, Vol 4, Iss 3, Pp 42-45 (2013)

В статье представлены подходы к повышению качества лечения артериальной гипертензии за счет выработки рациональной тактики применени�

Externí odkaz: https://doaj.org/article/fc2514ed031b48168804dbbf984d35bc

Zobrazit plný text záznamu

Akademický článek

Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii

Autor: Aleksandr Mikhaylovich Shilov

Publikováno v: Системные гипертензии, Vol 10, Iss 3, Pp 38-43 (2013)

В настоящем обзоре суммированы данные об эффективности блокаторов кальциевых каналов (БКК) при лечении артериальной гипертонии (АГ). Ле�

Externí odkaz: https://doaj.org/article/fb50b3d7513f40df8ac4645c5e140def

Zobrazit plný text záznamu

Ремодулювання серця у пацієнтів із хронічною хворобою нирок різної етіології

Autor: Daminov, B. T., Abdullayev, Sh. S., Egamberdieva, D. A.

Publikováno v: Bukovinian Medical Herald; Vol. 17 No. 4 (68) (2013); 54-58
Буковинский медицинский вестник; Том 17 № 4 (68) (2013); 54-58
Буковинський медичний вісник; Том 17 № 4 (68) (2013); 54-58

The study included 86 patients with chronic kidney disease (CKD) of stage III in the outcome of nephropathies of various genesis. The echogeometric heart parameters and an evaluation in a comparative aspect of the antiremodeling effects of eprosartan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::b2bf9ac1f99a8270eeaa2b272ca77d7e
http://e-bmv.bsmu.edu.ua/article/view/164274

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání